Prof. Hasan Mandal, president of the Scientific and Technological Research Council of Turkey (TÜBİTAK), explains how the COVID-19 platform coordinated by the agency has transformed the Turkish ecosystem by bringing together 436 researchers from 49 different institutions to collaborate on 17 drug and vaccine development projects. In addition, Prof. Mandal highlights the benefits of a co-creation approach and TÜBİTAK’s work with international organizations.
Co-creation based approaches are transforming the way R&D and innovation is being conducted with interactive processes replacing linear processes
